Roche Holding AG (RHHBF) Stock Price & Analysis
Roche Holding AG (RHHBF) — price $485.00 (+1.16%), as of the Nov 19, 2026 trading session; market cap $386B.
Educational signal · not a buy or sell recommendation · How to read this
Roche Holding AG · RHHBF · Healthcare · Drug Manufacturers - General
Founded in 1896 and headquartered in Basel, Switzerland, Roche Holding AG is a global enterprise active in both the pharmaceutical and diagnostics sectors.
Price as of Nov 19, 2026
Key Statistics
Not scored: MoonshotScore covers actively traded US operating companies, not funds, preferred shares, warrants or thinly traded stocks.
Thousands of the 20,000+ US stocks here carry a MoonshotScore.
Scored companies in the same industry:
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $485.00 | |
| Change on the day | +1.16% | |
| 52-week range | $375.00–$514.08 | |
| Market capitalisation | $386B | — |
| Price / earnings (trailing) | 26.45 | |
| Shares traded on the day | 1 | |
| Beta (volatility vs the S&P 500) | 0.35 |
Price & events
Point at or tab to any week for its close.
Other perspectives
Council score for Roche Holding AG (RHHBF): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Legends Council
6 lenses, 0 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Sep 10, 2026 · older than the 27 hours refresh window; not a current reading
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Sep 10, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Sep 10, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.
Readings on this page are from Nov 20, 2026, except a card that shows its own read date.
What is Roche Holding AG (RHHBF), and what does it report?
Short answer
Founded in 1896 and headquartered in Basel, Switzerland, Roche Holding AG is a global enterprise active in both the pharmaceutical and diagnostics sectors. Healthcare / Drug Manufacturers General Headquarters: Grenzacherstrasse 124, Basel, BS, 4070, CH. It employs 103,249 people and is led by Thomas Schinecker. In Q2 FY2026 it reported revenue of CHF 30.19B and net income of CHF 6.83B. The market values it at $386B.
What do the latest results show for Roche Holding AG (RHHBF)?
Short answer · as of
The most recent reported quarter, Q2 FY2026, carried revenue of CHF 30.19B. Against analyst estimates the company has EPS beat 5 of the last 8 reports.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q2 FY2026 | CHF 30.19B | CHF 6.83B | CHF 8.44 (diluted) |
| Q4 FY2025 | CHF 30.59B | CHF 5.47B | CHF 11.43 (diluted) |
| Q2 FY2025 | CHF 15.92B | CHF 3.71B | CHF 4.62 (diluted) |
| Q4 FY2024 | CHF 31.64B | CHF 2.02B | CHF 2.52 (diluted) |
What are the financial strengths and risks for Roche Holding AG (RHHBF)?
Short answer · as of
The distress and quality screens read Altman Z 5.31 · Piotroski F 6. Trailing ratios: ROE 37.1% · ROA 12.6% · current ratio 1.23 · earnings yield 3.7% · free-cash-flow yield 5.2%.
The records behind this page
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held RHHBF in their latest 13F filing, and what they did against the filing before it.
None of the 16 tracked investors reported RHHBF in their latest 13F filing.
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
What has been published about Roche Holding AG (RHHBF)?
RHHBF Healthcare Stock FAQ
These answers are editorial: 1 of these 8 answers is drawn from the RHHBF research dossier (written Jun 15, 2026 by gemini-2.5-flash); the other 7 are question templates that restate figures shown above. Figures in this section are not part of the source register.
Is RHHBF a good stock to buy?
Stock Expert AI does not rate RHHBF buy, sell or hold. Roche Holding AG has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.
What is the RHHBF stock price today?
The last price recorded for Roche Holding AG (RHHBF), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What does Roche Holding AG do?
Roche Holding AG is a global healthcare company based in Switzerland, operating in two primary divisions: pharmaceuticals and diagnostics. In its pharmaceutical segment, Roche develops and markets a wide range of therapies for serious medical conditions including cancer, neurological disorders, infectious diseases, and immunological conditions.
What are the key factors to evaluate for RHHBF?
Evaluate RHHBF on fundamentals, analyst consensus, and risk factors. To weigh it, start with the trailing P/E under Price & valuation on this page. Not financial advice.
How frequently does RHHBF data refresh on this page?
RHHBF's price is the last quote we recorded, from the Nov 19, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.
What has driven RHHBF's recent stock price performance?
Roche Holding AG (RHHBF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diversified business model across pharmaceuticals and diagnostics provides revenue stability. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider RHHBF overvalued or undervalued right now?
The trailing P/E of Roche Holding AG (RHHBF) is listed under Price & valuation on this page. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research RHHBF before investing?
Before investing in Roche Holding AG (RHHBF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 15, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 19 figures on this page — 15 from Financial Modeling Prep (FMP) and 4 with no recorded source. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com